Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

116.97
Delayed Data
As of Apr 27
 -3.31 / -2.75%
Today’s Change
55.36
Today|||52-Week Range
133.54
+29.39%
Year-to-Date

Today’s Trading

Previous close120.28
Today’s open120.72
Day’s range115.43 - 124.95
Volume2,543,980
Average volume (3 months)1,520,938
Market cap$19.3B
Dividend yield--
Data as of 3:59pm ET, 04/27/2015

Growth & Valuation

Earnings growth (last year)+28.13%
Earnings growth (this year)-146.42%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+36.76%
P/E ratioNM
Price/Sales17.64
Price/Book11.74

Competitors

 Today’s
change
Today’s
% change
PCYCPharmacyclics Inc+0.23+0.09%
INCYIncyte Corp-5.96-5.55%
ENDPEndo International P...-2.63-2.82%
HSPHospira Inc-0.37-0.42%
Data as of 4:01pm ET, 04/27/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)-$0.51
Annual revenue (last year)$750.0M
Annual profit (last year)-$134.0M
Net profit margin-17.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers